Oderda M, Orlando G, Calleris G, Capella G, et al. Role of Cell-Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2-ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance. Prostate 2025 May 29. doi: 10.1002/pros.24921.
PMID: 40437899